Back Pain Doctor
Proximal Hamstring Tendinopathy
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Proximal hamstring tendinopathy affects the hamstring tendons where they attach to the sit-bone (ischial tuberosity). It is a load-related condition, common in runners and in people who sit for long periods, and is felt as deep pain in the lower buttock.
The mainstay of treatment is a carefully graded hamstring loading program, introduced in a way that avoids over-compressing the tendon early on, alongside managing aggravating activities such as prolonged sitting. Recovery typically takes time and consistency.
For cases that do not respond to a well-structured loading program, additional options such as shockwave therapy may be considered. Assessment confirms the diagnosis, separates it from referred pain and other causes of buttock pain, and leads to a realistic, evidence-based plan.
A hamstring problem that began at a single identifiable moment (a sprint, a kick, a sudden reach at speed) is usually an acute hamstring strain rather than a tendinopathy. The two are assessed differently, imaged for different reasons, and rehabilitated along different lines, so distinguishing them early matters.
Common symptoms
- Deep pain around the sit-bone (lower buttock)
- Pain with prolonged sitting, especially on hard surfaces
- Pain with running, lunging or bending forward
- Tenderness over the hamstring attachment
Evidence for twelve treatment options in proximal hamstring tendinopathy
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Loading is the treatment, and the trials say adjuncts add little to it. A living network meta-analysis of 68 randomised trials across Achilles and patellar tendinopathy and gluteal tendinopathy found no convincing evidence that any adjunct, alone or added to exercise, beats exercise by itself, and recommended exercise alone for at least three months before an adjunct is considered (Challoumas, Sports Med Open 2023). A meta-analysis of 110 studies and 3,953 patients found greater effect where the programme added external load rather than body weight alone, and where sessions were less frequent than daily, allowing recovery (Pavlova, Br J Sports Med 2023). A 204-study synthesis found exercise safe, beneficial and acceptable to patients, with no clear superiority for the eccentric-only protocols long treated as standard (Cooper, Health Technol Assess 2023).
Pairing reviewed 2026-09-02.
Where it fits
This is the plan, not the preliminary. Expect a programme measured in months rather than weeks, with load progressed against your symptoms. Anything else offered here is an adjunct to it, and the evidence for adding one before three months of proper loading is weak.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. No study in this condition
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Searched 3 November 2026 (PubMed: trigger point injection, wet needling, dry needling or trigger point with adductor, groin, pubic, hamstring, posterior thigh or ischial, 54 records, all read). No study has injected a muscle trigger point in proximal hamstring tendinopathy, with glucose or anything else. The nearest are two case reports of runners treated with dry needling (nothing injected, not offered here) alongside eccentric hamstring loading and pelvic stability work, both returning to running and sitting without pain (Jayaseelan, J Orthop Sports Phys Ther 2014). The one controlled trial nearby went the other way: in 59 Australian Rules footballers with back-of-thigh pain referred from buttock trigger points, dry needling of the buttock muscles did no better than placebo needling, both groups improving equally (Huguenin, Br J Sports Med 2005). A systematic review of 13 studies in this condition recommends a loading program and notes needling only as part of combined care, with no separate result (Dizon, Sports 2023).
Pairing reviewed 2026-11-03.
Where it fits
Considered only where examination finds a tender hamstring or buttock muscle band contributing to the pain, as an adjunct to the tendon loading program, which treats the tendon itself.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Case series only, no trial
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
No randomised trial of a corticosteroid or anaesthetic injection in proximal hamstring tendinopathy was found; the evidence is uncontrolled. After ultrasound-guided corticosteroid injection, 50% of patients improved for more than a month and 24% for more than six months (Zissen, AJR Am J Roentgenol 2010). In 18 athletes (22 cases), a fluoroscopically guided injection beside the tendon was followed by pain falling from 7.2 to 3.9 out of 10 at a mean of 21 months, with 39% fully resolved, but there was no comparison group and outcomes were collected by questionnaire (Nicholson, Orthop J Sports Med 2014). A 2021 systematic review of 12 studies found insufficient evidence to favour any one treatment (Nasser, Int J Sports Phys Ther 2021).
Pairing reviewed 2026-10-30.
Where it fits
A loading programme is the main treatment. Where pain at the sitting bone is blocking it, a guided injection beside the tendon may be discussed, with the limited and often short-lived benefit explained. See the note on cortisone.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Good support
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Radial shockwave was superior to conservative treatment at short, mid and long term in proximal hamstring tendinopathy (Korakakis, Br J Sports Med 2017), and Level I evidence supports shockwave as a stand-alone treatment here (Rhim, Br J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
The form used in the trials for this diagnosis, alongside loading.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Good support
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Level I evidence for effectiveness as a stand-alone treatment in proximal hamstring tendinopathy (Rhim, Br J Sports Med 2024). The trial evidence used RADIAL shockwave, which was superior to conservative treatment at short, mid and long term (Korakakis, Br J Sports Med 2017).
Pairing reviewed 2026-08-30.
Where it fits
Offered alongside loading. Note the trials used radial rather than focused, and that is what would be used here.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Small case series; results vary
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Studied at the hamstring origin only in small groups, and never against a dummy injection. In 18 people with pain for an average of nearly three years, one ultrasound-guided injection was followed by an average 63% fall in pain at six months, with 10 of the 18 improving by 80% or more (Fader, Muscles Ligaments Tendons J 2014). In 22 people, 68% had at least halved their pain at an average of eight months (Auriemma, Regen Med 2020). An Australian study of 29 people with MRI-confirmed tendinopathy found the opposite: no significant change in the hamstring score eight weeks after a single injection, and 69% reporting no change in what they could do (Levy, J Sci Med Sport 2019). The one randomised trial compared PRP with an injection of the person's own whole blood, double-blind, and found no significant difference between them over six months (Davenport, J Ultrasound Med 2015). A systematic review of 12 studies rated that evidence very low and found too little to recommend any one treatment over another (Nasser, Int J Sports Phys Ther 2021). One serious complication has been reported, an infection of the sitting bone after a third injection, which settled with eleven weeks of antibiotics (Epshtein, JBJS Case Connect 2026).
Pairing reviewed 2026-10-09.
Where it fits
Discussed where a hamstring loading program has been done properly and has not been enough, usually after shockwave, which has the stronger trials at this tendon. If used, PRP is placed under ultrasound guidance with the sciatic nerve identified and avoided, and the modest and inconsistent evidence, the cost and the small infection risk are stated beforehand.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. One case report only
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No trial or case series of prolotherapy in hamstring tendinopathy was found. A PubMed search on 13 October 2026 (prolotherapy, dextrose or hypertonic glucose with hamstring, ischial tuberosity or ischial bursitis) returned five records, and passes restricted to randomised trials and to systematic reviews or meta-analyses found nothing in this condition. The only clinical record is a single case of tendinopathy at the lower end of the semimembranosus, behind the knee rather than at the sitting bone, in which three 12.5% dextrose injections gave no lasting relief before PRP was used (Senchyshak, Pain Med Case Rep 2026). The other records were a laboratory study of tendon cells, a nerve block, a different hip condition and an unrelated nutrition study. The prolotherapy trials sit at other tendons, chiefly the elbow, the shoulder and the plantar fascia (Capotosto, Orthop J Sports Med 2024: 20 trials, 1,136 people).
Pairing reviewed 2026-10-13.
Where it fits
Can be discussed for pain at the hamstring origin that persists despite a progressive loading program, with the absence of studies stated. It supports the loading program and does not replace it.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used for tendons
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Not offered here, and not studied. PubMed searches for hyaluronic acid with hamstring or ischial tuberosity terms (seven records once graft and ligament-reconstruction papers were excluded) and a randomised-trial pass across tendinopathy and bursitis (13 records) found no study of hyaluronic acid in proximal hamstring tendinopathy; it appears only as a passing mention in a review of hip injection treatments (Sullivan, J Hip Preserv Surg 2021). A meta-analysis of 19 randomised trials of hyaluronic acid in soft-tissue problems contains no hamstring trial (Khan, Sports Health 2022). This is an absence of evidence, not evidence that it fails.
Pairing reviewed 2026-11-09.
Where it fits
Not offered for this problem. Hyaluronic acid is considered only for a problem inside a joint, and this is a tendon problem. Progressive hamstring loading remains the centre of treatment.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
No study has tested small dextrose injections under the skin for hamstring tendinopathy. Searching the perineural injection, neural prolotherapy, subcutaneous dextrose, glucopuncture and neurofascial terms against the proximal hamstring and ischial terms returns no treatment study at this tendon, and a randomised-trial search across the dextrose and perineural terms on 6 October 2026 returned no record. The one dextrose report here is of the other procedure, and it did not work: a three-injection course of 12.5% dextrose prolotherapy gave no lasting relief or functional gain in a 61-year-old with chronic semimembranosus tendinopathy, who later improved with other treatment (Senchyshak, Pain Med Case Rep 2026). Where this row could matter is the skin nerve that runs beside the tendon origin. The posterior femoral cutaneous nerve can cause pain over the buttock and back of the thigh, has been reported trapped through overuse (Hu, Clin J Sport Med 2024), and has been injected under ultrasound with local anaesthetic with immediate partial relief and no adverse events reported, in a technique paper that gives no patient numbers and no follow-up (Vita, J Ultrasound 2025). Both are injections placed around the nerve under ultrasound, not a series just beneath the skin.
Pairing reviewed 2026-10-06.
Where it fits
Not a treatment for the tendon, which is managed with the options higher up this page. Considered only where sitting pain comes with tender, hypersensitive skin or altered sensation over the lower buttock and back of the thigh, suggesting a skin nerve is contributing.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No trial has tested hydrodissection for hamstring tendinopathy. The technique does appear at this site, but for a different problem: sciatic pain years after a complete tear of the hamstring origin, where dynamic ultrasound and MRI showed the retracted tendon scarred onto the sciatic nerve, treated by freeing the nerve under ultrasound guidance (Bohyn, Skeletal Radiol 2022). A radioanatomical study of 192 hips is a useful caution about how close these structures run: at the top of the femoral head the sciatic nerve sits within about 1.5 mm of bone, with nothing in between in over half of cases (Ollivier, Surg Radiol Anat 2026).
Pairing reviewed 2026-09-15.
Where it fits
Only where sitting pain at the hamstring origin comes with nerve symptoms down the back of the leg and the assessment suggests the sciatic nerve is tethered near the tendon, which is most likely after a significant tear. The tendinopathy itself is treated by the options higher up this page.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other hip & pelvis conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Why does sitting make it worse?
What is the main treatment?
When are other treatments considered?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment